*The following content is generated by AI and is for reference only.
Overview
Dapagliflozin is a selective SGLT2 inhibitor used in antidiabetic therapy. Synthesized via multi-step organic coupling, its molecular formula is C18H29NO7 and CAS number is 104828-75-7.
Application
- Pharmaceutical Manufacturing: Bulk production of branded metformin-combination tablets for Type 2 Diabetes management.
- Research & Development: Clinical trials investigating cardiovascular benefits and renal protection mechanisms.
Precautions
Strictly contraindicated in severe renal impairment or DKA. Store below 25°C in moisture-proof containers to prevent hydrolysis. Handle with PPE to avoid dermal absorption.